GL1X · GenesisL1 explorer

UniProt O14965

Aurora kinase A (O14965)

Aurora kinase A (UniProt O14965), EC 2.7.11.1: 297 experimental structures and 1 predicted model on GenesisL1, 76 ligands bound, 74 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
O14965
Protein
Aurora kinase A
EC
2.7.11.1
Experimental structures
297
Predicted models
1
Ligands
76
Pockets
74 · 30 records with a druggable one

Structures

298 records of O14965 in the MolNFT archive: 297 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1MQ4Crystal Structure of Aurora-A Protein Kinasex-ray diffractionA——
1MQ4Crystal structure of aurora-a protein kinasex-ray diffractionA——
1MUOCrystal structure of aurora-2, an oncogenic serine-threonine kinasex-ray diffractionA——
1MUOCrystal structure of aurora-2, an oncogenic serine- threonine kinasex-ray diffractionA——
1OL5Structure of Aurora-A 122-403, phosphorylated on Thr287, Thr288 and bound to TPX2 1-43x-ray diffractionA——
1OL5Structure of aurora-a 122-403, phosphorylated on THR287, THR288 and bound to TPX2 1-43x-ray diffractionA——
1OL6Structure of unphosphorylated D274N mutant of Aurora-Ax-ray diffractionA——
1OL6Structure of unphosphorylated D274N mutant of aurora-ax-ray diffractionA——
1OL7Structure of Human Aurora-A 122-403 phosphorylated on Thr287, Thr288x-ray diffractionA——
1OL7Structure of human aurora-a 122-403 phosphorylated on THR287, THR288x-ray diffractionA——
2BMCAurora-2 T287D T288D complexed with PHA-680632x-ray diffractionA, B, C, D, E, F——
2BMCAurora-2 T287D T288D complexed with pha-680632x-ray diffractionA, B, C, D, E, F——
2C6DAurora A kinase activated mutant (T287D) in complex with ADPNPx-ray diffractionA——
2C6DAurora a kinase activated mutant (T287D) in complex with adpnpx-ray diffractionA——
2C6EAurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitorx-ray diffractionA, B——
2C6EAurora a kinase activated mutant (T287D) in complex with a 5-aminopyrimidinyl quinazoline inhibitorx-ray diffractionA, B——
2DWBAurora-A kinase complexed with AMPPNPx-ray diffractionA——
2DWBAurora-a kinase complexed with amppnpx-ray diffractionA——
2J4ZStructure of Aurora-2 in complex with PHA-680626x-ray diffractionA, B——
2J4ZStructure of aurora-2 in complex with pha-680626x-ray diffractionA, B——
2J50Structure of Aurora-2 in complex with PHA-739358x-ray diffractionA, B——
2J50Structure of aurora-2 in complex with pha-739358x-ray diffractionA, B——
2NP8Structural Basis for the Inhibition of Aurora A Kinase by a Novel Class of High Affinity…x-ray diffractionA——
2NP8Structural basis for the inhibition of aurora a kinase by a novel class of high affinity…x-ray diffractionA——
2W1CStructure determination of Aurora Kinase in complex with inhibitorx-ray diffractionA——
2W1CStructure determination of aurora kinase in complex with inhibitorx-ray diffractionA——
2W1DStructure determination of Aurora Kinase in complex with inhibitorx-ray diffractionA——
2W1DStructure determination of aurora kinase in complex with inhibitorx-ray diffractionA——
2W1EStructure determination of Aurora Kinase in complex with inhibitorx-ray diffractionA——
2W1EStructure determination of aurora kinase in complex with inhibitorx-ray diffractionA——
2W1FStructure determination of Aurora Kinase in complex with inhibitorx-ray diffractionA——
2W1FStructure determination of aurora kinase in complex with inhibitorx-ray diffractionA——
2W1GStructure determination of Aurora Kinase in complex with inhibitorx-ray diffractionA——
2W1GStructure determination of aurora kinase in complex with inhibitorx-ray diffractionA——
2WQEStructure of S155R Aurora-A somatic mutantx-ray diffractionA——
2WQEStructure of S155R aurora-a somatic mutantx-ray diffractionA——
2WTVAurora-A Inhibitor Structurex-ray diffractionA, B, C, D——
2WTVAurora-a inhibitor structurex-ray diffractionA, B, C, D——
2WTWAurora-A Inhibitor Structure (2nd crystal form)x-ray diffractionA——
2WTWAurora-a inhibitor structure (2ND crystal form)x-ray diffractionA——
2X6DAurora-A bound to an inhibitorx-ray diffractionA——
2X6DAurora-a bound to an inhibitorx-ray diffractionA——
2X6EAurora-A bound to an inhibitorx-ray diffractionA——
2X6EAurora-a bound to an inhibitorx-ray diffractionA——
2X81Structure of aurora a in complex with MLN8054x-ray diffractionA——
2X81Structure of aurora a in complex with MLN8054x-ray diffractionA——
2XNEStructure of Aurora-A bound to an imidazopyrazine inhibitorx-ray diffractionA——
2XNEStructure of aurora-a bound to an imidazopyrazine inhibitorx-ray diffractionA——
2XNGStructure of Aurora-A bound to a selective imidazopyrazine inhibitorx-ray diffractionA——
2XNGStructure of aurora-a bound to a selective imidazopyrazine inhibitorx-ray diffractionA——
2XRUAurora-a T288E complexed with pha-828300x-ray diffractionA——
2XRUAurora-a T288E complexed with pha-828300x-ray diffractionA——
3COHCrystal structure of Aurora-A in complex with a pentacyclic inhibitorx-ray diffractionA, B——
3COHCrystal structure of aurora-a in complex with a pentacyclic inhibitorx-ray diffractionA, B——
3E5ACrystal structure of Aurora A in complex with VX-680 and TPX2x-ray diffractionA——
3E5ACrystal structure of aurora a in complex with vx-680 and TPX2x-ray diffractionA——
3EFWStructure of AuroraA with pyridyl-pyrimidine urea inhibitorx-ray diffractionA, B——
3EFWStructure of auroraa with pyridyl-pyrimidine urea inhibitorx-ray diffractionA, B——
3FDNStructure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and…x-ray diffractionA——
3FDNStructure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and…x-ray diffractionA——

238 records more on the page itself.

Ligands

  • MG · Magnesium ion · in 60 records
  • ADP · Adenosine-5'-diphosphate · in 48 records
  • CL · Chloride ion · in 26 records
  • SO4 · Sulfate ion · in 22 records
  • ANP · Phosphoaminophosphonic acid-adenylate ester · in 8 records
  • ATP · Adenosine-5'-triphosphate · in 8 records
  • ACP · Phosphomethylphosphonic acid adenylate ester · in 5 records
  • SKE · 4-({5-amino-1-[(2,6-difluorophenyl)carbonyl]-1H-1,2,4-triazol-3-yl}amino)benzenesulfonamide · in 4 records
  • 5DN · 2-(3-bromophenyl)-8-fluoroquinoline-4-carboxylic acid · in 3 records
  • P4G · 1-ethoxy-2-(2-ethoxyethoxy)ethane · in 3 records
  • T5L · (1~{R},2~{R})-cyclohexane-1,2-dicarboxylic acid · in 3 records
  • 5E1 · 2-(3-bromophenyl)quinoline-4-carboxylic acid · in 2 records
  • 627 · N-[(3E)-5-[(2R)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3(5H)-ylidene]-4-(4-methylpiperazin-1-yl)benzamide · in 2 records
  • 9A6 · 7-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]quinazolin-4-amine · in 2 records
  • 9YQ · 4-(propanoylamino)-~{N}-[4-[(5,8,11-trimethyl-6-oxidanylidene-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]benzamide · in 2 records
  • A5W · cyclobutyl-[4-(2-methoxyphenyl)piperidin-1-yl]methanone · in 2 records
  • A65 · [3,5-bis(methylsulfanyl)-1,2-thiazol-4-yl]methanol · in 2 records
  • A6W · methyl 3-azanyl-5-thiophen-2-yl-thiophene-2-carboxylate · in 2 records
  • A6Z · 2-[4-(3-chlorophenyl)piperazin-1-ium-1-yl]ethanenitrile · in 2 records
  • A98 · Methyl ~{N}-(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl) carbamate · in 2 records
  • AY4 · 2,4-bis(fluoranyl)-6-(1~{H}-pyrazol-3-yl)phenol · in 2 records
  • EGJ · (2S,4R)-1-[(3-chloro-2-fluorophenyl)methyl]-2-methyl-4-({3-[(1,3-thiazol-2-yl)amino]isoquinolin-1-yl}methyl) piperidine-4-carboxylic acid · in 2 records
  • G7W · (~{E})-~{N}-[4-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl]-4-[4-fluoranyl-3-(trifluoromethyl)phenyl]-4-oxidanylidene-but-2-enamide · in 2 records
  • GLC · alpha-D-glucopyranose · in 2 records
  • JRT · 2-(benzimidazol-1-yl)-~{N}-(2-phenylethyl)ethanamide · in 2 records
  • 35R · 1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea · in 1 record
  • 4QV · 5-hydroxy-1'H-1,2'-bibenzimidazol-2(3H)-one · in 1 record
  • 4RJ · 6-({4-[(Z)-{(2Z)-2-[(4-ethylphenyl)imino]-3-methyl-4-oxo-1,3-thiazolidin-5-ylidene}methyl]pyridin-2-yl}amino)pyridine-3-carboxylic acid · in 1 record
  • 4RM · (2Z,5Z)-2-[(4-ethylphenyl)imino]-3-(2-methoxyethyl)-5-(pyridin-4-ylmethylidene)-1,3-thiazolidin-4-one · in 1 record
  • 5E2 · 2-(3-bromophenyl)-6-chloroquinoline-4-carboxylic acid · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.